Tandem Oxidative Reaction of 1,3-Diarylpropenes and 5-Aminopyrazoles

Abstract

The reaction of 5-aminopyrazoles with 1,3-diarylpropenes mediated by 2,3-dichloro-5,6-dicyano-1,4-benzoquinone, with subsequent intramolecular cyclization and dehydroaromatization in the presence of Cu(OTf)₂/tert-butyl hydroperoxide, gave a series of pyrazolo[3,4-b]pyridines in moderate to excellent yields. The reaction has the advantages of high atom economy, a wide substrate scope, and a one-pot procedure.

Key words

oxidative coupling - tandem reaction - one-pot reaction - aminopyrazoles - diarylpropenes - pyrazolopyridines

Publikationsverlauf

Eingereicht: 30. Mai 2023

Angenommen nach Revision: 31. Juli 2023

Accepted Manuscript online:
31. Juli 2023

Artikel online veröffentlicht:
14. September 2023

• References and Notes


For representative examples, see:
• 1a Dodiya DK, Trivedi AR, Kataria VB, Shah VH. Curr. Org. Chem. 2012; 16: 400
• 1b Hu L, Li L, Chang Q, Fu S, Li Q. J. Med. Chem. 2020; 63: 11215
• 1c Abdel-latif E, Abdel-fattah S, Gaffer HE, Etman HA. Egypt. J. Basic Appl. Sci. 2016; 3: 118
• 1d Aly AA, El-Emary TI, Mourad A.-FE, Khallaf Alyan Z, Bräse S, Nieger M. J. Chem. Res. 2019; 43: 219
• 1e Donaire-Arias A, Montagut AM, Puig de la Bellacasa R, Estrada-Tejedor R, Teixidó J, Borrell JI. Molecules 2022; 27: 2237
• 1f Ji Y, Li L, Zhu G, Zhou Y, Lu X, He W, Gao L, Rong L. J. Heterocycl. Chem. 2020; 57: 1781
• 1g Liu N, Wang X, Fu Q, Qin Q, Wu T, Lv R, Zhao D, Cheng M. RSC Med. Chem. 2023; 14: 85
• 1h Mohamed MS, El-Deen Awad YS, El-Hallouty SM, El-Araby M. Open J. Med. Chem. 2012; 2: 78
• 1i Zhao B, Li Y, Xu P, Dai Y, Luo C, Sun Y, Ai J, Geng M, Duan W. ACS Med. Chem. Lett. 2016; 7: 629
• 2 El-Borai MA, Awad MK, Rizk HF, Atlam FM. Curr. Org. Synth. 2018; 15: 275
• 3 Hu Y, Kitamura N, Musharrafieh R, Wang J. J. Med. Chem. 2021; 64: 8755
• 4 Miyachi H, Yuzuriha T, Tabata R, Fukuda S, Nunomura K, Lin B, Kobayashi T, Ishimoto K, Doi T, Tachibana K. Bioorg. Med. Chem. Lett. 2019; 29: 2124
• 5 Goda FE, Abdel-Aziz AA.-M, Attef OA. Bioorg. Med. Chem. 2004; 12: 1845
• 6 Chandak N, Kumar S, Kumar P, Sharma C, Aneja KR, Sharma PK. Med. Chem. Res. 2013; 22: 5490
• 7a Saito MS, Lourenço AL, Dias LR. S, Freitas AC. C, Vitorino MI, Albuquerque MG, Rodrigues CR, Cabral LM, Dias EP, Castro HC, Satlher PC. J. Enzyme Inhib. Med. Chem. 2016; 31: 1591
• 7b da Silva Lima CH, de Araujo Vanelis Soares JC, de Ribeiro JL, Muri EM. F, de Albuquerque S, Dias LR. S. Lett. Drug Des. Discovery 2020; 17: 184
• 8a Zhong Y.-L, Lindale MG, Yasuda N. Tetrahedron Lett. 2009; 50: 2293
• 8b Faarasse S, El-Kazzouli S, Naas M, Jouha J, Suzenet F, Guillaumet G. J. Org. Chem. 2017; 82: 12300
• 8c Lavecchia G, Berteina-Raboin S, Guillaumet G. Tetrahedron Lett. 2004; 45: 2389
• 9a El-Emary TI. J. Chin. Chem. Soc. (Weinheim, Ger.) 2007; 54: 507
• 9b Ghaedi A, Bardajee GR, Mirshokrayi A, Mahdavi M, Shafiee A, Akbarzadeh T. RSC Adv. 2015; 5: 89652
• 10a Maqbool T, Khan MA, Khan MN, Elliott MC, Munawar MA, Nasrullah M, Bhatti AW, Nazeer A, Lin WO. Asian J. Chem. 2013; 25: 7715
• 10b Prakash R, Shekarrao K, Saikia P, Gogoi S, Boruah RC. RSC Adv. 2015; 5: 21099
• 10c Zhou Y, Wang L.-S, Lei S.-G, Gao Y.-X, Ma J.-T, Yu Z.-C, Wu Y.-D, Wu A.-X. Org. Chem. Front. 2022; 9: 4416

For representative examples, see:
• 11a Yao B, Miao T, Wei W, Li P, Wang L. Org. Lett. 2019; 21: 9291
• 11b Huang C.-Y, Kang H, Li J, Li C.-J. J. Org. Chem. 2019; 84: 12705
• 11c Pannilawithana N, Yi CS. ACS Catal. 2020; 10: 5852
• 11d Jha P, Husen S, Kumar R. Green Chem. 2021; 23: 2950
• 11e Fu L, Liu Y, Wan J.-P. Org. Lett. 2021; 23: 4363
• 11f Wu Y.-X, Huang M.-H, Peng K, Shi Z, Hao E.-J, Dong Z.-B. J. Org. Chem. 2022; 87: 2446
• 11g Takeda A, Okai H, Watabe K, Iida H. J. Org. Chem. 2022; 87: 10372
• 11h Lasso JD, Castillo-Pazos DJ, Li C.-J. Chem. Soc. Rev. 2021; 50: 10955
• 11i Batra A, Singh KN. Eur. J. Org. Chem. 2020; 43: 6676
• 11j Maikhuri VK, Maity J, Srivastava S, Prasad AK. Org. Biomol. Chem. 2022; 20: 9522
• 12 Tao Y, Gu H, Xia H, Yang H, Li J, Xu X, Cheng D. Eur. J. Org. Chem. 2023; e202201480
• 13a Khatun N, Banerjee A, Santra SK, Ali W, Patel BK. RSC Adv. 2015; 5: 36461
• 13b Mahesh D, Sadhu P, Punniyamurthy T. J. Org. Chem. 2016; 81: 3227
• 13c Khemnar AB, Bhanage BM. Org. Biomol. Chem. 2014; 12: 9631
• 13d Zhu X.-T, Lu Q.-L, Wang X, Zhang T.-S, Hao W.-J, Tu S.-J, Jiang B. J. Org. Chem. 2018; 83: 9890
• 13e Ratnikov MO, Doyle MP. J. Am. Chem. Soc. 2013; 135: 1549
• 14 Pyrazolo[3,4-b]pyridines 3a–gg; General Procedure DDQ (0.12 mmol, 1.2 equiv) was added to a solution of the appropriate 1,3-diarylpropene 2 (0.12 mmol, 1.2 equiv) in 1,4-dioxane (3 mL), and the mixture was stirred for 10 min. The appropriate 5-aminopyrazole 1 (0.10 mmol, 1.0 equiv) was then added, and the mixture was stirred at r.t. for 2 h. Cu(OTf)₂ (0.02 mmol, 0.2 equiv) and a solution of TBHP (0.2 mmol, 2.0 equiv) in decane (0.02 mL) were added, and the resultant mixture was stirred at 80 °C (oil bath) for 1 h. When the reaction was complete, the solvent was evaporated under reduced pressure, and the residue was purified by column chromatography [silica gel (200–300 mesh), PE–EtOAc (10:1–60:1)]. 1,3,4,6-Tetraphenyl-1H-pyrazolo[3,4-b]pyridine (3a) ¹⁵ Light-yellow solid; yield: 33.8 mg (80%). ¹H NMR (400 MHz, CDCl₃): δ = 8.63–8.60 (m, 2 H), 8.33–8.30 (m, 2 H), 7.79 (s, 1 H), 7.68–7.53 (m, 5 H), 7.44–7.25 (m, 9 H), 7.22–7.18 (m, 2 H). ¹³C NMR (100 MHz, CDCl₃): δ = 156.71, 152.02, 146.64, 145.90, 139.79, 139.11, 137.48, 133.00, 129.60, 129.36, 129.26, 129.02, 128.89, 128.42, 128.03, 127.82, 127.68, 127.63, 125.85, 121.56, 116.07, 112.20. HRMS (ESI): m/z [M + H]⁺ calcd for C₃₀H₂₂N₃: 424.1808; found: 424.1808.
• 15 Saleh TS, Eldebss TM. A, Albishri HM. Ultrason. Sonochem. 2012; 19: 49